Delivery Order SPE2DB22D3501-SPE2DB25FWX09
- Not listed
- The Defense Logistics Agency awarded a $4,002.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). This competitive award, with no set-aside designation, is a firm fixed-price contract that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at approximately $41K to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed price contract type. This award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,334.31 for 30-tablet units of Tivicay 50 mg tablets, a pharmaceutical product used in HIV treatment. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a firm fixed-price transaction with no set-aside designation. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,055.34 to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 mg tablets (30-count packages) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tivicay 50 mg tablets in quantities of 30, with a contract ceiling value of $23,342.52. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $8,005.86 delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) on June 17, 2025, with completion scheduled for June 18, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $20,950.35 to AmerisourceBergen Drug Corp for 30-count bottles of Tivicay 50 mg tablets. This competitive award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of TIVICAY 50 mg tablets (30-count units) with a ceiling value of $69,886.40. This firm fixed-price delivery order, with an ultimate completion date of April 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract valued at $10,353.99. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $4,178.97. This delivery order represents a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWX09Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,002.93 by the Defense Logistics Agency on August 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This competitively awarded, non-set-aside delivery order carries a firm fixed price structure with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio supporting federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and other government entities. The company maintains a substantial IDC valued at $999,999,999.00 through December 2026 that serves as the primary vehicle for supplying pharmaceuticals and medical commodities to military healthcare programs globally. Tivicay (dolutegravir) is an antiretroviral medication used in HIV treatment, reflecting the breadth of specialized pharmaceutical products AmerisourceBergen delivers through its federal contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/15/25 |